Formula Growth’s Marex Group Limited Ordinary Shares MRX Stock Holding History

Formula Growth’s Portfolio MRX Stock Details MRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$835K	Buy	+13,700	New	+$754K	0.29%	111

Other funds holding MRX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Formula Growth's MRX Position: Q2 2026 in Review

Formula Growth opened a new position in Marex Group Limited Ordinary Shares (MRX) in Q2 2026: 13,700 shares worth $835K. The stake represents 0.29% of the portfolio and ranks #111 among its holdings.

220 funds tracked by Wall St. Rank hold MRX as of Q2 2026.

Formula Growth held 13,700 shares of Marex Group Limited Ordinary Shares worth $835K as of Q2 2026.
Marex Group Limited Ordinary Shares was a new Formula Growth position in Q2 2026.
Marex Group Limited Ordinary Shares made up 0.29% of Formula Growth's portfolio in Q2 2026, its #111 holding.
220 funds tracked by Wall St. Rank held Marex Group Limited Ordinary Shares as of Q2 2026.

Based on Formula Growth's 13F filing for Q2 2026, filed 17 Aug 2026.